Skip to main content
. 2017 Dec 4;8(67):111631–111641. doi: 10.18632/oncotarget.22881

Figure 3. Changes in renal histopathology in mice with experimental MN shown by immunofluorescence staining for IgG.

Figure 3

Mice in the NC group (A–C) and MN group (D–F) were treated with PBS (A and D), etanercept (MN-Eta; B and E), or preligand assembly domain fusion protein (MN-PLAD; C and F), and quantitative data for immunofluorescence staining of IgG are shown in (G).